Literature DB >> 17223715

Modulation of diacylglycerol kinase theta activity by alpha-thrombin and phospholipids.

Becky Tu-Sekine1, Michele Ostroski, Daniel M Raben.   

Abstract

Diacylglycerol kinase modulates the levels of diacylglycerol and phosphatidic acid, two critical lipid second messengers, yet little is known about the effects of cellular stimulation on the kinetic behavior of this enzyme. We examined the effects of alpha-thrombin and activating phospholipids on the activity and substrate affinity of a soluble diacylglycerol kinase, DGKtheta. Our data demonstrate that the apparent binding parameters of DGKtheta increase following thrombin stimulation, suggesting that alpha-thrombin antagonizes DGKtheta activity. Interestingly, this effect is obscured in the presence of high bulk substrate concentrations. Given the known stimulatory effects of phosphatidylserine on many diacylglycerol kinases, we examined the effects of various phospholipids on DGKtheta and found that phosphatidic acid is a more effective activator than phosphatidylserine. Phosphatidic acid decreased the apparent surface K(M) (K(M(surf))app) of DGKtheta for dioleoylglycerol (DOG) and promoted binding to vesicles in a dose-dependent manner. Phosphatidylserine also lowered the K(M(surf))app of DGKtheta, though higher concentrations were required to achieve the same effect. Interestingly, PS promoted binding to vesicles only when present at levels beyond that required to saturate enzyme activity, suggesting that PS and PA activate DGKtheta through different mechanisms. The potential physiological implications of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17223715     DOI: 10.1021/bi061170c

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

Review 1.  Signaling at the membrane interface by the DGK/SK enzyme family.

Authors:  Daniel M Raben; Binks W Wattenberg
Journal:  J Lipid Res       Date:  2008-12-09       Impact factor: 5.922

2.  Dual regulation of diacylglycerol kinase (DGK)-θ: polybasic proteins promote activation by phospholipids and increase substrate affinity.

Authors:  Becky Tu-Sekine; Daniel M Raben
Journal:  J Biol Chem       Date:  2012-10-22       Impact factor: 5.157

3.  cAMP-stimulated transcription of DGKθ requires steroidogenic factor 1 and sterol regulatory element binding protein 1.

Authors:  Kai Cai; Marion B Sewer
Journal:  J Lipid Res       Date:  2013-04-22       Impact factor: 5.922

4.  Silencing diacylglycerol kinase-theta expression reduces steroid hormone biosynthesis and cholesterol metabolism in human adrenocortical cells.

Authors:  Kai Cai; Natasha C Lucki; Marion B Sewer
Journal:  Biochim Biophys Acta       Date:  2013-12-22

Review 5.  Phosphatidic acid and neurotransmission.

Authors:  Daniel M Raben; Casey N Barber
Journal:  Adv Biol Regul       Date:  2016-09-20

6.  Cyclic AMP-stimulated interaction between steroidogenic factor 1 and diacylglycerol kinase theta facilitates induction of CYP17.

Authors:  Donghui Li; Aarti N Urs; Jeremy Allegood; Adam Leon; Alfred H Merrill; Marion B Sewer
Journal:  Mol Cell Biol       Date:  2007-07-30       Impact factor: 4.272

7.  Diacylglycerol kinase θ couples farnesoid X receptor-dependent bile acid signalling to Akt activation and glucose homoeostasis in hepatocytes.

Authors:  Kai Cai; Marion B Sewer
Journal:  Biochem J       Date:  2013-09-01       Impact factor: 3.857

8.  Diacylglycerol kinase θ: regulation and stability.

Authors:  Becky Tu-Sekine; Hana Goldschmidt; Elizabeth Petro; Daniel M Raben
Journal:  Adv Biol Regul       Date:  2012-09-20

9.  Molecular determinants for interfacial binding and conformational change in a soluble diacylglycerol kinase.

Authors:  Agoston Jerga; Darcie J Miller; Stephen W White; Charles O Rock
Journal:  J Biol Chem       Date:  2008-12-27       Impact factor: 5.157

10.  Characterization of cellular DGK-theta.

Authors:  Becky Tu-Sekine; Daniel M Raben
Journal:  Adv Enzyme Regul       Date:  2009-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.